Expansion of vitiligo lesions is associated with reduced epidermal CDw60 expression and increased expression of HLA-DR in perilesional skin

British Journal of Dermatology

Volumn 149, Issue 4, 2003, Pages 739-748

  Le Poole, I C ^a   Stennett, L S ^a   Bonish, B K ^a   Dee, L ^a   Robinson, J K ^a   Hernandez, C ^a   Hann, S K ^b   Nickoloff, B J ^a  

^a LOYOLA UNIVERSITY HEALTH SYSTEM   (United States)

^b Yonsei University   (South Korea)

Author keywords

Cell mediated autoimmunity; Cytokines; Depigmentation; Ganglioside D3; Melanocytes

Indexed keywords

CDW60 ANTIGEN; CYTOKINE; GANGLIOSIDE GD3; HLA DR ANTIGEN; INTERLEUKIN 4 ANTIBODY; MEMBRANE ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; AUTOCRINE EFFECT; AUTOIMMUNITY; CANCER IMMUNOTHERAPY; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; DEPIGMENTATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREGULATION; MALE; MELANOCYTE; MELANOMA; PARACRINE SIGNALING; PERILESIONAL SKIN; PRIORITY JOURNAL; SKIN DEFECT; SKIN INFLAMMATION; TH1 CELL; TH2 CELL; VITILIGO;

ADULT; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; AUTOIMMUNE DISEASES; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; DISEASE PROGRESSION; EPIDERMIS; FEMALE; GANGLIOSIDES; HLA-DR ANTIGENS; HUMANS; IMMUNOENZYME TECHNIQUES; INTERLEUKIN-4; KERATINOCYTES; MALE; MELANOCYTES; MIDDLE AGED; VITILIGO;

EID: 0242635680     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2003.05539.x     Document Type: Article

References (39)

1. Le Poole IC, van den Wijngaard RMJGJ, Westerhof W et al. Presence or absence of melanocytes from vitiligo lesions: an immunohistochemical investigation. J Invest Dermatol 1993; 100: 816-22.
2. Boissy RE, Liu YY, Medrano EE, Nordlund JJ. Structural aberration of the rough endoplasmic reticulum and melanosome compartmentalization in long term cultures of melanocytes from vitiligo patients. J Invest Dermatol 1991; 97: 395-404.
3. Le Poole IC, Sarangarajan R, Zhao Y et al. 'VIT1', a novel gene associated with vitiligo. Pigment Cell Res 2001; 14: 475-84.
4. Das PK, van den Wijngaard RMJGJ, Wankowicz-Kalinska A, Le Poole IC. A symbiotic concept of autoimmunity and tumour immunity: lessons from vitiligo. Trends Immunol 2001; 22: 130-6.
5. Alkhateed A, Stetler GL, Old W et al. Mapping of an autoimmunity susceptibility locus (AIS1) to chromosome 1p31.3-p32.2. Hum Mol Genet 2002; 11: 661-7.
6. Harning R, Cui J, Bystryn JC. Relation between the incidence and level of pigment cell antibodies and disease activity in vitiligo. J Invest Dermatol 1991; 97: 1078-80.
7. Le Poole IC, van den Wijngaard RMJGJ, Westerhof W, Das PK. Presence of T cells and macrophages in inflammatory skin parallels melanocyte disappearance. Am J Pathol 1996; 148: 1219-28.
8. van den Wijngaard R, Wankowicz-Kalinska A, Le Poole C et al. Local immune response in skin of generalized vitiligo patients. Destruction of melanocytes is associated with the prominent presence of CLA+ T cells at the perilesional site. Lab Invest 2000; 80: 1299-309.
9. Yee C, Thompson JA, Roche P et al. Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of T cell-mediated vitiligo. J Exp Med 2000; 192: 1637-44.
10. Becker JC, Guldberg P, Zeuthen J et al. Accumulation of identical T cells in melanoma and vitiligo-like leucoderma. J Invest Dermatol 1999; 113: 1033-8.
11. Palermo B, Campanelli R, Garbelli S et al. Specific cytotoxic T lymphocyte responses against Melan-A/MART-1, tyrosinase and gp100 in vitiligo by the use of major histocompatibility complex/peptide tetramers; the role of cellular immunity in the etiopathogenesis of vitiligo. J Invest Dermatol 2001; 117: 326-32.
12. Del Porte G. The concept of type-1 and type-2 helper T cells and their cytokines in humans. Int Rev Immunol 1998; 16: 427-55.
13. Vizier C, Bercovici N, Heurtier A et al. Relative diabetogenic properties of islet-specific Tc1 and Tc2 cells in immunocompetent hosts. J Immunol 2000; 165: 6314-21.
14. Skov L, Chan LS, Fox DA et al. Lesional psoriatic T cells contain the capacity to induce a T cell activation molecule CDw60 on normal keratinocytes. Am J Pathol 1997; 150: 675-83.
15. Huang BB, Bonish BK, Chaturvedi V et al. Keratinocyte CDw60 expression is modulated by both a Th-1 type cytokine IFN-gamma and Th-2 cytokines IL-4 and IL-13: relevance to psoriasis. J Invest Dermatol 2001; 116: 305-12.
16. Giacomini P, Fisher PB, Durgon GJ et al. Regulation of class II MHC gene expression by interferons: insights into the mechanism of action of interferon (review). Anticancer Res 1988; 8: 1153-61.
17. Heidenheim M, Hansen ER, Baadsgaard O. CDw60, which identifies the acetylated form of GD3 gangliosides, is strongly expressed in basal cell carcinoma. Br J Dermatol 1995; 133: 392-7.
18. De Maria R, Lenti L, Malisan F et al. Requirement for GD3 ganglioside in CD95-and ceramide-induced apoptosis. Science 1997; 277: 1652-5.
19. Colell A, Garcia-Ruiz C, Roman J et al. Ganglioside GD3 enhances apoptosis by suppressing the nuclear factor-κB-dependent survival pathway. FASEB J 2001; 15: 1068-70.
20. Rippo MR, Malisan F, Ravagnan L et al. GD3 ganglioside directly targets mitochondria in a bcl-2-controlled fashion. FASEB J 2000; 14: 2047-54.
21. Van den Oord JJ, De Vandeghinste N, Ley M, De Wolf-Peeters C. Bcl-2 expression in human melanocytes and melanocytic tumors. Am J Pathol 1994; 145: 294-300.
22. Nakano J, Yasui H, Lloyd KO, Muto M. Biologic roles of gangliosides G (M3) and G (D3) in the attachment of human melanoma cells to extracellular matrix proteins. J Invest Dermatol Symp Proc 1999; 4: 173-6.
23. Birkle S, Gao L, Zheng G, Yu RK. Down-regulation of GD3 ganglioside and its O-acetylated derivative by stable transfection with antisense vector against GD3-synthase gene expression in hamster melanoma cells: effects on cellular growth, melanogenesis, and dendricity. J Neurochem 2000; 74: 547-54.
24. Kemminer SE, Konradt HS, Nimtz M et al. Production and molecular characterization of clinical phase I anti-melanoma mouse IgG3 monoclonal antibody R24. Biotechnol Prog 2001; 17: 809-21.
25. Kniep B, Flegel WA, Northoff H, Rieber EP. CDw60 glycolipid antigens of human leukocytes: structural characterization and cellular distribution. Blood 1993; 82: 1776-86.
26. Prendergast MM, Moran AP. Lipopolysaccharides in the development of the Guillain-Barré syndrome and Miller-Fisher syndrome forms of acute inflammatory peripheral neuropathies. J Endotoxin Res 2000; 6: 341-59.
27. Moretti S, Spallanzani A, Amato L et al. Vitiligo and the epidermal microenvironment: possible involvement of keratinocytes-derived cytokines. Arch Dermatol 2002; 138: 273-4.
28. Moretti S, Spallanzani A, Amato L et al. New insights into the pathogenesis of vitiligo: imbalance of epidermal cytokines at sites of lesions. Pigment Cell Res 2002; 15: 87-92.
29. Hybbinette S, Bostrom M, Lindberg K. Enzymatic dissociation of keratinocytes from human skin biopsies for in vitro cell propagation. Exp Dermatol 1999; 8: 130-8.
30. Le Poole IC, Boissy RE, Sarangarajan R et al. PIG3V, an immortalized human vitiligo melanocyte cell line, expresses dilated endoplasmic reticulum. In Vitro Cell Dev Biol Anim 2000; 36: 309-16.
31. Boukamp P, Petrussevska RT, Breitkreutz D et al. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 1988; 106: 761-71.
32. Gasparro F. The role of PUVA in the treatment of psoriasis: Photobiology issues related to skin cancer incidence. Am J Clin Dermatol 2000; 1: 337-48.
33. Papadavid E, Yu RC, Munn S, Chu AC. Strict anatomical coexistence of vitiligo and psoriasis: a Koebner phenomenon? Clin Exp Dermatol 1996; 21: 138-40.
34. Furukawa X, Arita Y, Satomi N et al. Tumor necrosis factor enhances GD3 ganglioside expression in cultured human melanocytes. Arch Biochem Biophys 1990; 281: 70-5.
35. Fox DA, Davis W, Zeldes W et al. Activation of human T cell clones through the UM4D4/CDw60 surface antigen. Cell Immunol 1990; 128: 480-9.
36. Ortaldo JR, Mason AT, Longo DL et al. T cell activation via the disialoganglioside GD3: analysis of signal transduction. J Leukoc Biol 1996; 60: 533-9.
37. Boussiotis VA, Pardo NA, Collins H et al. R24 anti-GD3 ganglioside antibody can induce costimulation and prevent the induction of alloantigen-specific T cell clonal anergy. Eur J Immunol 1996; 26: 2149-54.
38. Weite B, Handgretinger R, Rassner G, Fierlbeck G. Expression of GD3 disialoganglioside antigen on peripheral T-lymphocytes in patients with disseminated malignant melanoma. Exp Dermatol 1997; 6: 64-9.
39. Wrone-Smith T, Mitra RS, Thompson CB et al. Keratinocytes derived from psoriatic plaques are resistant to apoptosis compared with normal skin. Am J Pathol 1997; 151: 1321-9.